The intensity of DiOC6in cells was measured using FACScan flow cytometer. THF-ACGs induced apoptotic phenomena were monitored by The Annexin V-FITC Apoptosis Detection Kit II (BD Biosciences Pharmingen) according to the manufacturers instructions. verified by real-time PCR, Western blot and shRNA gene knockdown experiments. Although our results showed that squamostatin A-induced ESR was impartial of extracellular Ca2+, the presence of extracellular Ca2+enhanced the antiproliferative effect of acetogenins. In vivoanalyses demonstrated that squamostatin A showed good pharmacokinetic properties and significantly retarded NPC tumor growth in the xenograft mouse model. Conclusively, our work demonstrates that acetogenins are effective and selective inducers from the ESR that can block NPC proliferation, and illustrate a previously unappreciated antitumor mechanism of acetogenins that is effective against nasopharyngeal malignancies. The incident of nasopharyngeal carcinoma (NPC) is very prevalent in South-East Asia, particular in Guangdong province of China (25 cases per 100, 000 people)1and also is the tenth leading cause of mortality among male cancer patients in Taiwan. Due to the anatomical location of the nasopharynx, early detection of NPC during routine physical exams has proven to be very difficult. Consequently, 20% of all NPC patients have distant metastases in the bone, lung, mediastinum and liver at the time of diagnosis2. As a result, the five-year survival rate of NPC patients is between 10 and 40%3. Although many clinical trials have shown that patients receiving pre-radiation chemotherapy with methotrexate (MTX), cisplatin and 5-fluorouracil could significantly improve the five-year survival rate of metastatic NPC patients4, 5, a considerable number of NPC patients develop drug-resistance and succumb to NPC due to disease progression. Therefore , new and effective treatments intended for NPC patients are urgently needed. Because the incidence of NPC in Western societies is relatively low and the development of new therapeutics for NPC has not been a high priority for many pharmaceutical institutions, the discovery of new pharmaceutical agents focusing on NPC has been a high priority for the scientific community and governmental health agencies in South-East Asia for many years. A-1155463 In the past 30 years, the scientific field offers successfully recognized numerous useful chemicals from natural sources for the treatment of diseases6. Annonaceousacetogenins (ACGs) are compounds discovered exclusively inAnnonaceousplants in tropical and subtropical regions of South-East Asia. MostAnnonaceousacetogenins are characterized by unique C32or C34unbranched fatty acids with a single, adjacent or nonadjacent tetrahydrofuran (THF) or tetrahydropyran (THP), oxygen-bearing moieties and a -lactone at the end of fatty acid chain7. In 1982, uvaricin was identified as the first ACG compound and contained potent anti-tumor activity with an IC50in the nanomolar range. ACG derivatives have since become promising new pharmaceutical candidates intended for treating various cancers8, 9, 10and chemo-resistant malignancies11. However , after more than three decades of intensive research, with over 400 natural and synthetic ACGs tested12, the mechanism of action remains largely elusive. Several molecular pathways have been proposed, such as disruption of mitochondrial complex I13, the generation of superoxide anion and hydrogen peroxide14, decreases in both cAMP and cGMP levels15, the induction of cell-cycle A-1155463 arrest16, 17or apoptotic cell death induced by elevated cytosolic Ca2+18. However , none of these mechanisms are able to fully explain the anti-tumor properties observed of ACGs19. The lack of a defined biological mechanism of action offers greatly hindered the usage of ACGs as antitumor agents in the clinic. The endoplasmic reticulum (ER) is involved in the folding and post-translational modification of secretory and membrane-bound proteins, lipid biosynthesis and intracellular calcium homeostasis20, 21and is crucial for normal cellular function and survival. In addition to the biosynthetic capacity, the ER is the highest concentrations calcium that contains organelle in the cell A-1155463 and sequestered calcium can be released in response to secondary messengers, protein kinases and other modulators22, 23. Multiple disturbances, including nutrient deprivation, A-1155463 hypoxia, redox stimulation and disturbances of calcium flux, lead to the accumulation of unfolded A-1155463 and/or misfolded proteins in the ER lumen, causing ER-stress responses (ESR)24. ESR triggers the unfolded protein response (UPR), a distinctive cytoprotective Rabbit polyclonal to CCNB1 signaling cascade25that is intended to re-establish homeostasis and normal ER function by.